We are delighted to announce the appointment of the new Head of the QA/RA business area Anna-Karin Alm. She assumes the QA/RA business area head position in Aurevia and will lead the Aurevia QA/RA organization in Sweden and Finland. Anna-Karin is a member of the Aurevia Management team and acts as the Managing Director of QAdvis AB in Sweden. She reports to Aurevia CEO Juha-Pekka Nuutinen. Aurevia QA/RA team offers regulatory affairs and quality assurance services to medical device and in vitro diagnostics companies.
Anna-Karin holds a Master of Science in Mechanical Engineering from the Royal Institute of Technology (KTH) and is certified as a Six Sigma Black Belt. With over 20 years of experience in leading roles within the Medical Technology sector, Anna-Karin is dedicated to defining and improving organizations and has worked in medical devices throughout her career. She brings a diverse set of leadership skills to Aurevia, having held positions such as CEO, Director of Medical Device Compliance, and Director of Operational Excellence. Anna-Karin has also led multiple cross-functional and cross-cultural development teams and improvement projects. Most recently, she has worked at Prevas AB (SDS MedteQ AB) and SHL Group AB.
“I am happy to welcome Anna-Karin to the Aurevia team. I am confident that she has the right knowledge and experience to define the winning business strategy for our growing QA/RA operations. Her strong insight on the Medtech business, regulatory frameworks, and related markets will bring value to our customers and their operations,” says CEO Juha-Pekka Nuutinen from Aurevia.
“I feel proud to be part of this experienced and skilled team of quality and regulatory experts within Aurevia and QAdvis. Our team has a broad set of skills, not only within our business area but also with colleagues within the CRO part of the organization. Together we will enable access for clients to the best experts, supporting our clients in optimizing their product development and quality management work,” concludes Anna-Karin Alm.
Anna-Karin started her new role on February 1, 2025. She will have an important role in building and developing Aurevia’s QA/RA organization and operations.
For queries, please contact:
Juha-Pekka Nuutinen
CEO | Aurevia
+358 40 828 3210 | juha-pekka.nuutinen@aurevia.com
AUREVIA
As Aurevians, we are the excellence makers: a team of experienced experts in healthcare and health-tech standards and quality. Together, we advance healthcare, pharmaceutical and medical technology development with a future-focused approach, aligned with client needs. Driven by our commitment to care, we contribute quality to the industry and pave the way for safer, more effective patient care worldwide.
We are a full-service, rapid-response Contract Research Organization (CRO) and external quality assessment services (EQAS) provider. Our quality services for the healthcare, pharmaceutical, and medical technology industries cover external quality assessments, quality assurance, regulatory affairs, clinical investigations and trials, audits and certifications, and training. Our expertise and knowledge benefit medical device and in vitro diagnostic manufacturers, pharmaceutical companies, healthcare units, and clinical laboratories.
Currently, we serve over 8000 customers in over 60 countries around the world. Our team comprises nearly 200 skilled professionals in offices in Finland, Sweden, Poland, and Germany. Aurevia is supported by Mérieux Equity Partners.
Aurevia – empowering clients with excellence-driven solutions to achieve the highest standards in patient care.
Share this article
